Abstract
The prognosis of oncology patients admitted to the intensive care unit (ICU) is considered poor. Our objective was to analyze the characteristics and predictive factors of death in the ICU and functional outcome following ICU treatment for neuro-oncology patients. A retrospective study was conducted on all patients with primary brain tumor admitted to our institutional ICU for medical indications. Predictive impact on the risk of death in the ICU was analyzed as well as the functional status was evaluated prior and following ICU discharge. Seventy-one patients were admitted to the ICU. ICU admission indications were refractory seizures (41 %) and septic shock (17 %). On admission, 16 % had multi-organ failure. Ventilation was necessary for 41 % and catecholamines for 13 %. Twenty-two percent of patients died in the ICU. By multivariate analysis, predictive factors associated with an increased risk of ICU death were: non-neurological cause of admission [p = 0.045; odds ratio (OR) 5.405], multiple organ failure (p = 0.021; OR 8.027), respiratory failure (p = 0.006; OR 9.615), and hemodynamic failure (p = 0.008; OR 10.111). In contrast, tumor type (p = 0.678) and disease control status (p = 0.380) were not associated with an increased risk of ICU death. Among the 35 evaluable patients, 77 % presented with a stable or improved Karnofsky performance status following ICU hospitalization compared with the ongoing status before discharge. In patients with primary brain tumor admitted to the ICU, predictive factors of death appear to be similar to those described in non-oncology patients. ICU hospitalization is generally not associated with a subsequent decrease in the functional status.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kostakou E, Rovina N, Kyriakopoulou M, Koulouris NG, Koutsoukou A (2014) Critically ill cancer patient in intensive care unit: issues that arise. J Crit Care 29:817–822
Kulkarni AP, Divatia JV (2013) A prospective audit of costs of intensive care in cancer patients in India. Indian J Crit Care Med 17:292–297
Wigmore TJ, Farquhar-Smith P, Lawson A (2013) Intensive care for the cancer patient—unique clinical and ethical challenges and outcome prediction in the critically ill cancer patient. Best Pract Res Clin Anaesthesiol 27:527–543
Aygencel G, Turkoglu M, Turkoz Sucak G, Benekli M (2014) Prognostic factors in critically ill cancer patients admitted to the intensive care unit. J Crit Care 29:618–626
de Montmollin E, Tandjaoui-Lambiotte Y, Legrand M et al (2013) Outcomes in critically ill cancer patients with septic shock of pulmonary origin. Shock Augusta Ga 39:250–254
Lamia B, Hellot M-F, Girault C, Tamion F, Dachraoui F, Lenain P, Bonmarchand G (2006) Changes in severity and organ failure scores as prognostic factors in onco-hematological malignancy patients admitted to the ICU. Intensive Care Med 32:1560–1568
Azoulay E, Moreau D, Alberti C, Leleu G, Adrie C, Barboteu M, Cottu P, Levy V, Le Gall JR, Schlemmer B (2000) Predictors of short-term mortality in critically ill patients with solid malignancies. Intensive Care Med 26:1817–1823
Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963
Vincent J-L, Marshall JC, Namendys-Silva SA et al (2014) Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir Med 2:380–386
Thiéry G, Azoulay E, Darmon M, Ciroldi M, De Miranda S, Lévy V, Fieux F, Moreau D, Le Gall JR, Schlemmer B (2005) Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol Off J Am Soc Clin Oncol 23:4406–4413
Ferrà C, Marcos P, Misis M et al (2007) Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: a single-center experience. Int J Hematol 85:195–202
Chinot OL, Wick W, Mason W et al (2014) Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med 370:709–722
Soussain C, Hoang-Xuan K, Taillandier L et al (2008) Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire. J Clin Oncol Off J Am Soc Clin Oncol 26:2512–2518
Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580–637
Sampson JH, Heimberger AB, Archer GE et al (2010) Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. J Clin Oncol Off J Am Soc Clin Oncol 28:4722–4729
Chang Y, Huh J-W, Hong S-B, Lee DH, Suh C, Kim S-W, Lim C-M, Koh Y (2014) Outcomes and prognostic factors of patients with lung cancer and pneumonia-induced respiratory failure in a medical intensive care unit: a single-center study. J Crit Care 29:414–419
Soares M, Silva UVA, Teles JMM, Silva E, Caruso P, Lobo SMA, Dal Pizzol F, Azevedo LP, de Carvalho FB, Salluh JIF (2010) Validation of four prognostic scores in patients with cancer admitted to Brazilian intensive care units: results from a prospective multicenter study. Intensive Care Med 36:1188–1195
Soares M, Toffart A-C, Timsit J-F et al (2014) Intensive care in patients with lung cancer: a multinational study. Ann Oncol Off J Eur Soc Med Oncol ESMO 25:1829–1835
Kim YJ, Kim M-J, Cho Y-J et al (2014) Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients. Med Oncol Northwood Lond Engl 31:847
Azoulay E, Mokart D, Pène F et al (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium—a groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol Off J Am Soc Clin Oncol 31:2810–2818
Larché J, Azoulay E, Fieux F, Mesnard L, Moreau D, Thiery G, Darmon M, Le Gall J-R, Schlemmer B (2003) Improved survival of critically ill cancer patients with septic shock. Intensive Care Med 29:1688–1695
Azoulay E, Alberti C, Bornstain C, Leleu G, Moreau D, Recher C, Chevret S, Le Gall JR, Brochard L, Schlemmer B (2001) Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med 29:519–525
Acknowledgments
This work was completed in the SIRIC of Marseille, grant INCa-DGOS-Inserm 6038. ARTCsud.
Authors’ Contribution
ET conceived the study, participated in its design, acquired and analysed data and drafted the manuscript. RD conceived the study, participated in its design, analyzed data and helped to draft the manuscript. SB, MB, CB, and DA participated in the acquisition of data. SB help to draft the manuscript. OC and NB participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No potential conflict of interest relevant to this article was reported.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Tabouret, E., Boucard, C., Devillier, R. et al. Neuro-oncological patients admitted in intensive-care unit: predictive factors and functional outcome. J Neurooncol 127, 111–117 (2016). https://doi.org/10.1007/s11060-015-2015-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-015-2015-7